⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4806763 | 0.75 | — | — | |
| SCHEMBL534389 | 0.70 | — | — | |
| SCHEMBL1337213 | 0.67 | — | — | |
| SCHEMBL5981733 | 0.67 | SORT1 (0.31) | — | |
| SCHEMBL2091553 | 0.65 | ALDH1A1 (0.46) | — | |
| SCHEMBL2096161 | 0.62 | APP (0.48) | — | |
| SCHEMBL636217 | 0.42 | — | — | |
| SCHEMBL330965 | 0.41 | IDO1 (0.41) | — | |
| SCHEMBL1995763 | 0.39 | — | — | |
| SCHEMBL11319189 | 0.36 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150175587-A1 | SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO AND ANALOGUES THEREOF | SLOAN KETTERING INST CANCER (US) | 2015-06-25 | — | — | US | disclosed |
| US-20140213618-A1 | SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO AND ANALOGUES THEREOF | SLOAN KETTERING INST CANCER (US) | 2014-07-31 | — | — | US | disclosed |
| US-8513429-B2 | Synthesis of epothilones, intermediates thereto and analogues thereof | SLOAN-KETTERING INSITUTE FOR CANCER RESEARCH (US) | 2013-08-20 | — | — | US | disclosed |
| US-20120316348-A1 | SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO AND ANALOGUES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2012-12-13 | — | — | US | disclosed |
| US-8110590-B2 | Synthesis of epothilones, intermediates thereto and analogues thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2012-02-07 | — | — | US | disclosed |
| US-7875638-B2 | desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; isomerization of the double bonds in the ring | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2011-01-25 | — | — | US | disclosed |
| US-20100197746-A1 | SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO AND ANALOGUES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2010-08-05 | — | — | US | disclosed |
| US-7759374-B2 | 12,13-desoxyepothilones, used as anticarcinogenic agents | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2010-07-20 | — | — | US | disclosed |
| EP-2186811-A1 | Synthesis of epothilones, intermediates thereto, analogues and uses thereof | Sloan-Kettering Institute For Cancer Research (US) | 2010-05-19 | — | — | EP | disclosed |
| US-7649006-B2 | Administering epothilones or desoxyepothilones to a cancer patient as anticarcinogenic agent | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2010-01-19 | — | — | US | disclosed |
| US-20070032534-A1 | 12,13-desoxyepothilones, used as anticarcinogenic agents | DANISHEFSKY SAMUEL J | 2007-02-08 | — | — | US | disclosed |
| EP-1506203-B1 | SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO, ANALOGUES AND USES THEREOF | SLOAN KETTERING INST CANCER (US) | 2007-01-03 | — | — | EP | disclosed |
| EP-1722791-A2 | SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO, ANALOGUES AND USES THEREOF | Sloan Kettering Institute For Cancer Research (US) | 2006-11-22 | — | — | EP | disclosed |
| WO-2005084222-A2 | SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO, ANALOGUES AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2005-09-15 | — | — | WO | disclosed |
| US-6921769-B2 | Synthesis of epothilones, intermediates thereto and analogues thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2005-07-26 | — | — | US | disclosed |
| US-20050143429-A1 | Synthesis of epothilones, intermediates thereto, analogues and uses thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2005-06-30 | — | — | US | disclosed |
| EP-1506203-A2 | SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO, ANALOGUES AND USES THEREOF | Sloan-Kettering Institute For Cancer Research (US) | 2005-02-16 | — | — | EP | disclosed |
| US-20040053995-A1 | Synthesis of epothilones, intermediates thereto and analogues thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2004-03-18 | — | — | US | disclosed |
| US-20040053910-A1 | Administering epothilones or desoxyepothilones to a cancer patient as anticarcinogenic agent | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2004-03-18 | — | — | US | disclosed |
| WO-2004018478-A2 | SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO, ANALOGUES AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2004-03-04 | — | — | WO | disclosed |